SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiome -- CRME -- Ignore unavailable to you. Want to Upgrade?

To: dr.praveen who wrote (78)9/13/2006 9:28:37 AM
From: zeta1961  Respond to of 285
 
I read it as positive that 600mg showed good safety (despite no increased efficacy)..do you have PK/PD data to support 150mg dosing?....for all we know, they're playing hard to get in their PR's..bwdik?

I just don't see them being able to stay indie..Elisabeth

Bought some more pre last results and keeping it in LT..hoping for a buy-out..have owned it since 03!..Regardless, I'm happy that a low-SAE drug is progressing in this indication..



To: dr.praveen who wrote (78)9/13/2006 9:31:32 AM
From: Ian@SI  Read Replies (1) | Respond to of 285
 
Can one really make any definitive statement about efficacy in such a small Ph2 trial?

I missed the conference call. My monitor died and I spent the early part of the morning swapping out the old and putting in a new one. Did anyone catch it? Any clarification on safety - I really couldn't get a good impression from the PR.

thanks,
Ian


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News